Chemoinformaics analysis of 4-Isopropyl-6-methyltetralone
| Molecular Weight | 202.297 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 12 |
| Exact Molecular Weight | 202.136 | nRing | 2 |
| Solubility: LogS | -5.218 | nHRing | 0 |
| Solubility: LogP | 3.961 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 36.1843 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.678 |
| Synth | 2.775 |
| Natural Product Likeliness | 0.955 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.555 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.523 |
| MDCK | 0.0000193 |
| BBB | 0.971 |
| PPB | 0.921597 |
| VDSS | 0.529 |
| FU | 0.0764399 |
| CYP1A2-inh | 0.36 |
| CYP1A2-sub | 0.93 |
| CYP2c19-inh | 0.805 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.659 |
| CYP2c9-sub | 0.823 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.673 |
| CYP3a4-inh | 0.3 |
| CYP3a4-sub | 0.584 |
| CL | 6.995 |
| T12 | 0.162 |
| hERG | 0.04 |
| Ames | 0.261 |
| ROA | 0.141 |
| SkinSen | 0.044 |
| Carcinogencity | 0.431 |
| EI | 0.324 |
| Respiratory | 0.633 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.718137 |